People

Professor Wen Jiang

Professor Wen Jiang

Chair

School of Medicine

Email:
jiangw@cardiff.ac.uk
Telephone:
+44 (0)29 2068 7065
Location:
UHW Main Building

I have a long-standing interest in cancer metastasis and from 1987, my main research interest has been on the molecular and cellular basis of cancer invasion and metastasis and therapeutic aspects of targeting cancer metastasis. I have been particularly interested in the bone, peritoneal and brain metastasis from primary tumours including breast, prostate, lung, GI cancers. My research has been conducted in Cardiff's School of Medicine and I have collaborated widely with colleagues in the UK, China, Europe, North America and Asia.

Education and qualifications:

  • 1995, MD research degree, University of Wales College of Medicine
  • 1984, Primary medical degree (MB, BCh) in Clinical Medicine, Peking University Health Science Centre (Previously Beijing Medical University)

Career overview:

  • 2014 - present: Dean of International, Cardiff University 
  • 2012 - present: Director of Cardiff China Medical Research Collaborative
  • 2012 - present: Quality and Safety Improvement Faculty, National Health Service/UHB, National Health Service
  • 2012 - present: Academic Director for International Relations, Cardiff University
  • 2004 - present: Professor of Surgery and Tumour Biology, Cardiff University School of Medicine
  • 2003 - 2004: Reader, University of Wales College of Medicine
  • 1997 - 2003: Senior Lecturer, University of Wales College of Medicine
  • 1996 - 1997: Senior Fellow, University of Wales College of Medicine
  • 1989 - 1996: Research Fellow, University of Wales College of Medicine (currently Cardiff University's School of Medicine)
  • 1987 - 1989: Chief Surgical Resident, Department of General Surgery, Peking University First Hospital, Beijing
  • 1984 - 1987: Surgical Resident, Department of General Surgery, Peking University First Hospital, Beijing

Honours and awards

  • Fellow of the Royal Society of Biology
  • Fellow of the Royal Society of Medicine
  • Honorary professorship at Peking University
  • Honorary professorship at Capital Medical University
  • Honorary professorship at Inner Mongolia University
  • Honorary professorship at QingDao University
  • International consultant for Beijing Lung Cancer Centre

Recent awards include: 

  • Member of the Most Excellent Order of the British Empire
  • Marquis Who's Who as Prominent Cancer Researcher
  • Outstanding Achievement Award, 19th World Congress of Oncology, Athens, Greece, October 2014
  • Super Professor in America's Academic Row, June 2015

Professional memberships

  • Member of the American Association for Cancer Research (AACR)
  • Member of the British Association for Cancer Research (BACR)
  • Member of the European Association for Cancer Research (EACR)

Academic positions

  • 2014 - present: Dean of International, Cardiff University 
  • 2012 - present: Director of Cardiff China Medical Research Collaborative
  • 2012 - present: Quality and Safety Improvement Faculty, National Health Service/UHB, National Health Service
  • 2012 - present: Academic Director for International Relations, Cardiff University
  • 2004 - present: Professor of Surgery and Tumour Biology, Cardiff University School of Medicine
  • 2003 - 2004: Reader, University of Wales College of Medicine
  • 1997 - 2003: Senior Lecturer, University of Wales College of Medicine
  • 1996 - 1997: Senior Fellow, University of Wales College of Medicine
  • 1989 - 1996: Research Fellow, University of Wales College of Medicine (currently Cardiff University's School of Medicine)
  • 1987 - 1989: Chief Surgical Resident, Department of General Surgery, Peking University First Hospital, Beijing
  • 1984 - 1987: Surgical Resident, Department of General Surgery, Peking UniversityFirst Hospital, Beijing

Speaking engagements

Recent speaking engagements include:

  • 2017: International Gastic Cancer Conference
  • 2016: Gordon Conference, Gerona, Spain
  • 2016: British Society of Pharmacology
  • 2016: GOC 2016, Prague
  • 2016: 12th International Conference on Collateral Disease (Oncology Forum), Shanghai, China
  • 2015: 11th International Conference on Collateral Disease, Shijiazhuang, China
  • 2014: Peking University Postgraudate Society
  • 2014: 19th World Congress on Advances in Oncology, Athens
  • 2014: 9th International Conference of Anticancer Research, Sithonia
  • 2013: Phoenix TV, Chinese Medicine in cancer therapies
  • 2013: BBC report on new medicine in cancer treatment

Committees and reviewing

  • 2014 - present: Member of the University International Board

Other academic activities:

Editorship:

  • Editor-in-Chief: World Journal of Oncology
  • Editor-in-Chief: Cancer Metastasis, Biology and Treatment http://www.springer.com/series/5761
  • Editor-in-Chief: Journal of Molecular and Genetic Medicine http://www.omicsonline.com/open-access/molecular-genetic-medicine.php

Editorial Board membership includes:

  • Member of the editorial board of the International Journal of Molecular Medicine, from 1999
  • Advisory Board Member, ‘Advances in Therapy’, from 2008
  • Editorial Board Member, ‘Current Oncology’, from 2008
  • Editorial Board Member, ‘Journal of Surgical Oncology’, from 2008
  • Editorial Board Member, ‘Current Signal Transduction Therapy’, from 2009
  • Editorial Board Member, ‘World Journal of Gastroenterology’, from 2009
  • Editorial Board Member, ‘Experimental and Therapeutic Medicine’, from 2009
  • Editorial Board Member, ‘World Journal of Clinical Oncology’, From 2010
  • Editorial Board Member, ‘World Journal of Oncology’, From 2010
  • Editorial Board Member, ‘Chinese Journal of Cancer Research’, From 2010
  • Editorial Board Member, ‘Current Cancer Therapy Reviews’, From 2010
  • Editorial Board Member, ‘International Journal of Oncology'', from 2011
  • Editorial Board Member, ‘Translational Medicine: Current Research'', from 2011
  • Editorial Board Member, ‘Translational Gastrointestinal Cancer'', from 2011
  • Editorial Board Member, ‘Biomedical Reports'', from 2012
  • Editorial Board Member, ‘World Journal of Medical Genetics (WJMG)'', from 2012
  • Academic consultant, 'Antitumour Pharmacy', from 2012
  • Editorial Board Member: 'Journal of Cancer Research and Therapy', from 2012
  • Editorial Board Member: 'Angiology', from 2012
  • Editorial Board Member: 'AO Translational Research', from 2013
  • Editorial Board Member: 'Chinese Journal of Biology', from 2013
  • Editorial Board Member: 'Academic Journal of Capital Medical University', from 2013
  • Editorial Board Member: 'Cancer Genomics and Proteomics', from 2014
  • Editorial Board Member: 'Insight of Medical Physics', from 2015
  • Editorial Board Member: 'Cancer Translational Medicine', from 2015
  • Editorial Board Member: 'Biochemical and Biophysical Acta (BBA) Clinical'', from 2015
  • Editorial Board Member: 'Cancer Hypothesis', from 2016

Books published

  • ‘Cancer Metastasis, molecular and cellular basis and clinical intervention’, Editors Wen G Jiang and Robert E Mansel,  Kluwer Academic Publishers,  2000 (ISBN 0-7923-6395-7). (http://www.springer.com/gb/book/9780792363958)
  • ‘Growth Factors and their receptors in cancer metastasis’, Editors Wen G Jiang, Toshikazu Nakamura and Kunio Matsumoto, Kluwer Academic Publishers,  2001 (ISBN 0-7923-7141-0)   (http://www.springer.com/gb/book/9780792371410) 
  • ‘Breast Cancer Metastasis’, Editors Robert E Mansel, Oystein Fodstad and Wen G Jiang, Spinger Publishers,  2007, ISBN: 978-1-4020-5866-0.  (http://www.springer.com/gb/book/9781402058660) 
  • 'Electric Cell-Substrate Sensing in the investigation of cancer and cancer metastasis'. Wen G Jiang. Springer Publishers, 2012. ISBN 978-94-007-4926-9 (http://www.springer.com/biomed/cancer/book/978-94-007-4926-9) 
  • 'Tight junctions in cancer metastasis'. TA Martin and WG Jiang. Springer Publishers, March 2013 (ISBN 978-94-007-6027-1). (http://www.springer.com/gb/book/9789400760271)
  • Molecular Pathology Module
  • HGF/cMET in the osteoblastic metastasis of prostate cancer, molecular, cellular and therapeutic implications, in collaboration with Professor Malcolm D Mason
  • Molecular finger printing of genes linked to cancer progression
  • Novel molecular wound healing signature, in collaboration with Professor Keith Harding
  • The molecular, cellular and clinical impacts of SOCS, suppressor of cytokine signalling, in human wound healing, in collaboration with Professor Keith Harding
  • Anti-metastasis (including peritoneal metastasis) medicines, in collaboration with Peking University and Yiling Research Institute (Professor Jiafu Ji and Professor Yiling Wu)
  • Brain Metastasis Research Platform, in collaboration with Capital Medical University (Professors Junqi He and Wei Ding)
  • Evaluation of transglutaminase-4 as a therapeutic target and diagnostic tool in human prostate cancer, in collaboration with Professor Malcolm D Mason and Professor Richard J Ablin (University of Arizona)
  • Biomarkers in human colorectal cancer research programme, in collaboration with Capital Medical University (Professors Junqi He and Wei Ding)
  • Cancer Metastasis Platform, in collaboration with Wales Life Science Network